Tom joined ATV in 2004 and focuses on healthcare investments, with a specific focus on medical devices, diagnostics, imaging and technology enabled services .  He represents ATV on the boards of Aperio, Gynesonics, PolyRemedy, and Valeritas.  He is also an observer on the boards of ConcepTx, Helixis, and Zeltiq Aesthetics.

Prior to joining ATV, Tom had 12 years of operating experience in the healthcare industry, most recently serving as Vice President of corporate strategy and business development at McKesson Corporation, a leading company in the healthcare IT and pharmaceutical/medical device services industries. In this role Tom managed a variety of successful initiatives including the launch of McKesson’s Medicare Prescription Drug Card, the origination of a direct sourcing channel for generic pharmaceuticals from India, the evolution of the company’s RFID and e-prescribing strategies, and acquisitions of Moore Medical and Sky Pharmaceuticals.

Prior to McKesson, Tom was a Product Manager at Genentech and was responsible for the successful Nutropin™, Nutropin AQ™ and Pulmozyme™ franchises. In addition, he managed sales and oversaw healthcare strategy for FitLinxx, a venture-backed startup that pioneered the fitness and rehab monitoring market.

His management background also includes five years consulting at The Wilkerson Group where he focused on medical devices and diagnostics.

Tom holds an M.B.A. from the Wharton School and a B.A. from the University of Pennsylvania and was an All American rugby player and former New Hampshire State math champion.

Email: trodgers@atvcapital.com

Representative Investments

Aperio
Gynesonics
PolyRemedy
Valeritas
Sub-One Technology
Helixis